Literature DB >> 165733

Mechanism of cholecystokinin inhibition of lower esophageal sphincter pressure.

R S Fisher, A J DiMarino, S Cohen.   

Abstract

The purpose of this study were 1) to quantify the lower esophageal sphincter (LES) response to intravenous cholecystokinin (CCK) in both man and the opossum in vivo, 2) to characterize the interaction of CCK and gastrin on circular muscle of the LES, and 3) to determine the site of action of CCK on LES muscle. In both man and the opossum LES pressure was decreased significantly by either constant intravenous infusion or bolus injection of CCK. In vitro dose-response curves to gastrin I, CCK, and the octapeptide of CCK (OP) demonstrated that both CCK and OP were partial agonists on the LES muscle. Both CCK and OP contract LES muscle at lower threshold doses, but give smaller maximum responses than gastrin I. The maximum response of LES muscle to CCK was antagonized only by atropine and tetrodotoxin, but not by other antagonists, suggesting that CCK contracts LES muscle by acetylcholine release. In vitro studies on LES muscle showed that CCK selectively antagonized the effect of gastrin I, but not other agonists. These studied suggest that CCK reduces LES pressure in vivo by inhibition of the endogenous gastrin effect.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165733     DOI: 10.1152/ajplegacy.1975.228.5.1469

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans.

Authors:  J Boulant; S Mathieu; M D'Amato; A Abergel; M Dapoigny; G Bommelaer
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

2.  Relationship between postprandial esophageal acid exposure and meal volume and fat content.

Authors:  K Iwakiri; M Kobayashi; M Kotoyori; H Yamada; T Sugiura; Y Nakagawa
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

3.  Effect of desamino-cholecystokinin-octapeptide (CCK-7) on the intraluminal pressure and myoelectrical activity of the gall-bladder, stomach, and small intestine in conscious dogs.

Authors:  E Milenov; K Nieber; H Niedrich; P Oehme; W E Vogt
Journal:  Br J Pharmacol       Date:  1983-12       Impact factor: 8.739

4.  Effects of cerulein on esophageal motor activity and L.E.S. pressure in achalasia.

Authors:  G Fegiz; A Paolini; M Annessi; F Felli; M Cardi; A Veneziani
Journal:  World J Surg       Date:  1982-07       Impact factor: 3.352

5.  Cholecystokinin induces esophageal longitudinal muscle contraction and transient lower esophageal sphincter relaxation in healthy humans.

Authors:  Arash Babaei; Ravinder Mittal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-14       Impact factor: 4.052

6.  Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man.

Authors:  A A Masclee; J B Jansen; L C Rovati; C B Lamers
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

7.  Effect of cholecystokinin on lower oesophageal sphincter pressure and transient lower oesophageal sphincter relaxations in humans.

Authors:  M Ledeboer; A A Masclee; M R Batstra; J B Jansen; C B Lamers
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 8.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.